Beta Drugs Limited (NSE:BETA)

Beta Drugs Revenue

Beta Drugs had revenue of 2.04B INR in the half year ending September 30, 2025, with 44.12% growth. This brings the company's revenue in the last twelve months to 3.86B, up 15.20% year-over-year. In the fiscal year ending March 31, 2025, Beta Drugs had annual revenue of 3.62B with 22.54% growth.

• Revenue (ttm): 3.86B
• Revenue Growth: +15.20%
• P/S Ratio: 3.93
• Revenue / Employee: 9.67M
• Employees: 399
• Market Cap: 15.17B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	3.62B	666.42M	22.54%
Mar 31, 2024	2.96B	686.00M	30.21%
Mar 31, 2023	2.27B	432.76M	23.54%
Mar 31, 2022	1.84B	677.16M	58.31%
Mar 31, 2021	1.16B	253.16M	27.88%